Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Folia Histochemica Et Cytobiologica|July 12, 2011
JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patientsBożena Sokołowska, Aleksandra Nowaczyńska, Ksenia Bykowska, et al.
Cancers|December 9, 2023
Clonal Neoantigen: Emerging "Mechanism-based" Biomarker of Immunotherapy ResponseJohn Nemunaitis, Laura Stanbery, David Willoughby, et al.
The Journal of Gene Medicine|May 26, 2026
In Vivo Assessment of dbDNA GNEwt/bi-shRNA-GNEM743T Lipoplex for GNE Myopathy: Improved Potency and SafetyChristopher M Jay, Fabienne Kerneis, Donald Rao, et al.
Future Oncology (London, England)|March 24, 2025
Clinical characterization and therapeutic targeting of fusion genes in oncologySusan Morand, Lauren Rager, Daniel Craig, et al.
Future Science OA|March 2, 2026
Preclinical assessment of GNEwt/bi-shRNA-GNEM743T lipoplex product development for GNE myopathyFabienne Kerneis, Christopher M Jay, Donald Rao, et al.
Gynecologic Oncology|November 15, 2024
Repair Assisted Damage Detection (RADD) as a predictive biomarker for immunotherapy response in ovarian cancerManoj Sonavane, Jenna Hedlich-Dwyer, Valeria L Dal Zotto, et al.
Vaccines|August 28, 2021
Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian CancerRodney P Rocconi, Laura Stanbery, Luciana Madeira da Silva, et al.
Gynecologic Oncology Reports|June 7, 2021
Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648]Jonathan Oh, Minal Barve, Neil Senzer, et al.
Leukemia Research|July 15, 2010
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study GroupAnna Dmoszynska, Adam Walter-Croneck, Iwona Hus, et al.
Obstetrics and Gynecology|October 24, 2012
Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancerSamith Sandadi, Stephen Lee, Adam Walter, et al.
Pageof 6